Special Issues

Special Issues
December 2019 Highlights from the First Annual Cholangiocarcinoma Summit
View this Issue
2019 Fourth Annual Oncology Guide to New FDA Approvals
View this Issue
Mechanism of Pathway: Considerations of Cytogenetic and Molecular Mutation Status for Patients with Acute Myeloid Leukemia: A Deeper Look at the Role of Diagnostic and Ongoing Testing Across the Care Continuum
View this Issue
2018 Third Annual Oncology Guide to New FDA Approvals
View this Issue
Front-Line Treatment of Patients with Advanced Hodgkin Lymphoma
View this Issue
June 2017, Vol 8, No 3, Supplement 2: The Evolution of Chemotherapy-Induced Nausea and Vomiting Management: Challenges and Opportunities
View this Issue
Highlights from Best Practices in Lung Cancer Navigation Summit
View this Issue
February 2017, Vol 8, No 1, Supplement 1: Balancing Innovation and Value in Cancer Care: Spotlight on Non–Small-Cell Lung Cancer Treatment
View this Issue
Consolidation Therapy After ASCT in Hodgkin Lymphoma: Why and Who to Treat
View this Issue
August 2016, Vol 7, No7, Special Issue: Payers’ Perspectives in Oncology
View this Issue
Mechanism of Action Magnifier – 2016 Desk Reference
View this Issue
Dx Profiler: Can Metastatic Cancer with Diagnostic Ambiguity Be Treated Based on Mutational Status Alone?
View this Issue
Mechanism of Pathway: Phosphatidylserine, an Immune-Modulating Checkpoint, Ushers in the Next Wave of Immuno-Oncology Targets
View this Issue
Mechanism of Action: Key Advances in Hematology Oncology
View this Issue
Mechanism of Action: Novel Mechanisms in Lung Cancer
View this Issue
Mechanism of Action: Novel Mechanisms in CINV Treatment
View this Issue
Mechanism of Pathway: The Promise of PD-1 Pathway Blockade in the Treatment of Metastatic Cancer
View this Issue